Isomorphic Labs 与强生宣布跨模态、多靶点研究合作
Public reviewed event · Tue Jan 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
Event summary
据 Isomorphic Labs 官方公告，与 Johnson & Johnson 开展研究合作，结合 AI 药物发现与药物开发能力。此公告中的强生集团暂不强行归为本库某个业务实体。
Public evidence and original sources
Isomorphic Labs Enters into a Research Collaboration with Johnson & Johnson This partnership brings together Iso’s AI-first approach to drug discovery with Johnson & Johnson’s expertise in drug discovery and development.
Isomorphic Labs official announcements
- Isomorphic Labs · AI, models, and data ·